HPV immunization in Brazil and proposals to increase adherence to vaccination campaigns
DOI:
https://doi.org/10.11606/s1518-8787.2023057005410Keywords:
Human papillomavirus, Uterine Cervical Neoplasms, Social Marketing, Immunization, Immunization ProgramsAbstract
OBJECTIVES: To identify the possible causes of low adherence to vaccination campaigns in Brazil, find and analyze campaigns regarding human papillomavirus (HPV) in Brazil and abroad, and apply quality tools to prepare proposals to increase vaccination coverage (VC) and prevent HPV in the country. METHOD: This is a qualitative and deductive-hypothetical research. A narrative review of the literature (especially on the narratives and formats applied in vaccination campaigns in Brazil) was the technique used to develop our method. RESULTS: Brazil had a 49.6% VC in 2019, unlike countries such as Australia (80.2% in 2017), Mexico (97.5% in 2019), and Peru (91% in 2019). This study found evidence of the use of social marketing strategies to engage communities as good practices in the vaccination campaigns of these countries. CONCLUSION: With the retrieved information, three quality tools (Ishikawa diagram, Pareto graph, and 5W2H) classified and quantified the causes of low VC in Brazil and enabled proposals that can direct its Ministry of Health to take more effective strategies to achieve the HPV VC goal recommended by the WHO.
References
Nakagawa JT, Schirmer J, Barbieri M. Vírus HPV e câncer de colo de útero. Rev Bras Enferm. 2010;63(2):307-11. https://doi.org/10.1590/S0034-71672010000200021
Instituto Nacional do Câncer. Perguntas frequentes: HPV. Brasília, DF: Ministério da Saúde; 2020 [citado 20 maio 2021]. Disponível em: https://www.gov.br/inca/pt-br/acesso-a-informacao/perguntas-frequentes/hpv
World Health Organization. Human papillomavirus (HPV) and cervical cancer. Geneva: World Health Organization; 2020 [citado 29 abr 2021]. Disponível em: https://www.who.int/newsroom/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
Instituto Nacional do Câncer. Estatísticas de câncer. Brasília, DF: Ministério da Saúde;2021 [citado 20 maio 2021]. Disponível em: https://www.inca.gov.br/numeros-de-cancer
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças Transmissíveis. Informe técnico sobre a vacina papilomavírus humano (HPV) na atenção básica. Brasília, DF: Ministério da Saúde; 2013.
World Health Organization. Human Papillomavirus (HPV) vaccination coverage. Geneva: World Health Organization; 2021 [citado 31 jan 2022]. Disponível em: https://immunizationdata.who.int/pages/coverage/hpv.html
Kotler P, Lee NR. Marketing social: Influenciando comportamentos para o bem. 3rd ed. Porto Alegre: Bookman; 2011.
Nowak GJ, Gellin BG, MacDonald NE, Butler R. Addressing vaccine hesitancy: the potential value of commercial and social marketing principles and practices. Vaccine. 2015 Aug;33(34):4204-11. https://doi.org/10.1016/j.vaccine.2015.04.039
Santos AAM, Guimarães EA, Brito GP. Gestão da qualidade: conceito, princípio, método e ferramentas. Revista Científica Intermeio. 2013;1:91–110.
Fregnani JH, Carvalho AL, Eluf-Neto J, Ribeiro KC, Kuil LM, Silva TA, et al. A school-based human papillomavirus vaccination program in Barretos, Brazil: final results of a demonstrative study. PLoS One. 2013 Apr;8(4):e62647. https://doi.org/10.1371/journal.pone.0062647
McRee AL, Gilkey MB, Dempsey AF. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care. 2014;28(6):541-9. https://doi.org/10.1016/j.pedhc.2014.05.003
Cancer Institute NSW. Cervical screening campaigns. 2004 [citado 8 fev 2022]. Disponível em:
Australian Institute of Health and Welfare. Cervical screening in Australia 2019. Cervical screening in Australia 2019. Canberra: Australian Institute of Health and Welfare; 2019. (Cancer series, v. 123. Cat. no. CAN 124).
Heredia-Caballero ÁG, Palacios-López GG, Castillo-Hernández MC, Hernández-Bueno AI, Medina-Arizmendi FV. Prevalencia y tipificación de genotipos de virus del papiloma humano en mujeres del área metropolitana del Valle de México. Ginecol Obstet Mex. 2017;85(12):809-18.
Melo K. Índice de mulheres que fizeram Papanicolau em 2019 foi de 81,3%. Agência Brasil. 2022 [citado 4 jun 2022]. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2022-03/indice-de-mulheres-que-fizeram-papanicolau-em-2019-foi-de-813.
Escobar H. Orçamento federal para 2022 mantém ciência brasileira em situação de penúria. Jornal da USP [Internet]. 14 dez. 2021 [citado 13 set 2023]. Disponível em: https://jornal.usp.br/atualidades/orcamento-2022-mantem-ciencia-brasileira-em-situacao-de-penuria/
Ministerio de Salud (PE). Yo me vacuné contra el VPH. Vacúnate tú también. 2021 [citado 21 fev 2022]. Disponível em: https://www.gob.pe/institucion/minsa/campañas/364-yo-me-vacune-contra-el-vph-vacunate-tu-tambien
Cates JR, Diehl SJ, Crandell JL, Coyne-Beasley T. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine. 2014 Jul;32(33):4171-8. https://doi.org/10.1016/j.vaccine.2014.05.044
Portillo-Romero AJ, León-Maldonado L, Allen-Leigh B, Brown B, Magis C, García-Fuentes NB, et al. HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV. Salud Publica Mex. 2018;60(6):658-65. https://doi.org/10.21149/10182
Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010 Sep;126(3):425-33. https://doi.org/10.1542/peds.2009-3500
Silva EC, Mazzon JA. Social marketing plan for health promotion: developing public health policies customer-oriented. Rev Bras Mark. 2016;15(2):164-76. https://doi.org/10.5585/remark.v15i2.2907
Australian Institute of Health and Welfare. Cervical screening in Australia 2019. Canberra: Australian Institute of Health and Welfare; 2019.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Wagner Mesojedovas Santos, Debora Mesojedovas Santos, Márcia Santana Fernandes
This work is licensed under a Creative Commons Attribution 4.0 International License.
